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Abstract
Summary This is the first national study of public and patient
research priorities in osteoporosis and fracture. We have iden-
tified new research areas of importance to members of the
public, particularly ‘access to information from health profes-
sionals’. The findings are being incorporated into the research
strategy of the National Osteoporosis Society.
Purpose This study aimed to prioritise, with patients and public
members, research topics for the osteoporosis research agenda.
Methods An e-survey to identify topics for research was
co-designed with patient representatives. A link to the
e-survey was disseminated to supporters of the UK National
Osteoporosis Society (NOS) in a monthly e-newsletter.
Responders were asked to indicate their top priority for re-
search across four topics (understanding and preventing oste-
oporosis, living with osteoporosis, treating osteoporosis and
treating fractures) and their top three items within each topic.
Descriptive statistics were used to describe demographics and
item ranking. A latent class analysis was applied to identify a
substantive number of clusters with different combinations of
binary responses.
Results One thousand one hundred eighty-eight (7.4%) re-
spondents completed the e-survey. The top three items overall
were ‘Having easy access to advice and information from
health professionals’ (63.8%), ‘Understanding further the
safety and benefit of osteoporosis drug treatments’ (49.9%)
and ‘Identifying the condition early by screening’ (49.2%).
Latent class analysis revealed distinct clusters of responses
within each topic including primary care management and
self-management. Those without a history of prior fracture
or aged under 70 were more likely to rate items within the
cluster of self-management as important (21.0 vs 12.9 and
19.8 vs 13.3%, respectively).
Conclusion This is the first study of public research priorities
in osteoporosis and has identified new research areas of im-
portance to members of the public including access to infor-
mation. The findings are being incorporated into the research
strategy of the National Osteoporosis Society.
Keywords Research priorities . Patient and public
involvement and engagement . Survey . Osteoporosis .
Fracture
Introduction
Sixteen years ago, Tallon et al. published a high profile call to
bridge the gap between research agendas and consumer views
in osteoarthritis [1]. Patients wanted more rigorous evaluation
of the effects of surgery and physiotherapy and better assess-
ment of the educational and coping strategies that might help
patients to manage this chronic, disabling and often painful
condition. They had little enthusiasm for drug trials, yet these
Electronic supplementary material The online version of this article
(doi:10.1007/s11657-017-0340-5) contains supplementary material,
which is available to authorized users.
* Zoe Paskins
z.paskins@keele.ac.uk
1 Arthritis Research UK Primary Care Centre, Research Institute for
Primary Care Sciences, Keele University, Keele, Staffordshire ST5
5BG, UK
2 Haywood Academic Rheumatology Centre, Staffordshire and
Stoke-on-Trent Partnership Trust, Stoke-on-Trent ST6 7AG, UK
3 Oxford Trauma, Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences, University of Oxford,
Oxford, UK
4 National Osteoporosis Society, Bath BA2 0PJ, UK
Arch Osteoporos  (2017) 12:45 
DOI 10.1007/s11657-017-0340-5
constituted the vast majority of the published studies of treat-
ments for this condition [1, 2].
Historically, members of the public have been less likely to
be consulted about research priorities than clinicians and other
stakeholders [3]. A number of cultural assumptions have been
identified which may underpin a reluctance to set priorities
with patients. These include the belief that patients may shift
focus away from basic science and a feeling that researchers
are best placed to identify priorities [4].
Increasingly, policy makers and public funders recognise
the importance of involving public and patients in setting pri-
orities for research to ensure that research agendas are
patient-centred, relevant and that research outcomes have a
high likelihood of resulting in patient benefit. Ensuring that
research addresses the priorities of research users is also one of
four strategies proposed to reduce waste and increase value of
research [5]. Over the last decade, a number of initiatives such
as INVOLVE, part of the National Institute for Health
Research (NIHR), have been established to facilitate and pro-
mote active public involvement in all aspects of research, in-
cluding priority setting. The James Lind Alliance (JLA) was
formed in 2004 and aimed to bring patients and clinicians
together in a new way to identify and address important un-
certainties about the effects of care and treatments [6]. These
initiatives are by no means limited to the UK; existing litera-
ture evidences health research priority setting exercises with
users in the USA, Canada and Australia in addition to the UK
[7]. Furthermore, the European League Against Rheumatism
(EULAR) has recognised the pivotal role of patients in the
development of recommendations [8]. Unfortunately, despite
this apparent revolution in patient engagement, recent evi-
dence suggests the mismatch between the research patients
want and the research that is conducted still persists [9].
Furthermore, a previous report commissioned by the JLA
established that the majority of charitable funders in the UK
funded research in a responsive mode, with only a minority
funding research that only met pre-identified priorities [4].
With respect to osteoporosis, no studies to date have investi-
gated the research priorities of patients and members of the
public, which is surprising given the extent and impact of the
condition [10, 11].
This study, conducted by researchers in conjunction with a
charitable funder, the National Osteoporosis Society (NOS)
aimed to prioritise, with patients and public members, a list
of research topics for the osteoporosis research agenda.
Methods
An e-survey to prioritise topics for research was co-designed
with a patient research user group based on the findings from
previous qualitative research using a combination of
face-to-face methods to identify topics and online survey for
voting is part of a suite of recommended methods by the
Cochrane Methods Priority Setting group [12]. The categories
and items for the e-survey were previously derived from four
focus groups with members of the public conducted in two
UK cities [13]. Participants for the focus groups were recruited
from members of the National Osteoporosis Society (NOS)
(Staffordshire) and a research cohort (Oxford) of individuals
who had experienced fracture. In the focus groups, partici-
pants were asked to describe their experience of osteoporosis,
what was important to them, what problems they had had,
what was missing from their care/management and what could
be improved. Qualitative analysis identified four topics (un-
derstanding and preventing osteoporosis, living with osteopo-
rosis, treating osteoporosis and treating fractures). For each
topic, a number of subthemes were identified (Table 1).
Researchers worked with a patient research user group at
Keele [14] to translate each subtheme into a questionnaire
stem for the e-survey; ZP wrote an initial draft which the
patient group subsequently edited, ensuring that each stem
represented discussion in the focus group and was written in
an understandable way [15]. The user group consisted of five
Table 1 Topics and subthemes used for e-survey
Understanding and preventing
osteoporosis (OP)
Living with osteoporosis Treating osteoporosis Treating fractures
Awareness of OP in general population
Promoting bone health in
• Schools
• Well man/woman clinics
Role of diet
Role of exercise
Identifying new causes
Role of screening
Understanding bone physiology
Prognosis
Genetics
Impact on
• Activities of daily living
• Employment
• Relationships
Managing pain
Anxiety and depression
Managing OP with comorbidity
Fear of fracture
Support from other organisations
Role of advice and information
Improving attitudes to OP
GP care
Communication between primary
and secondary care
Self-management
Safety and benefit of supplements
Safety and benefit of drugs
Complementary treatments
Role of exercise
Stratified treatment
Follow up: role of
• DXA
• Annual review
Diagnosis of fractures
Managing pain
Short-term occupational therapy
Period of immobilisation
Effect of OP and drugs on fracture
healing
Role of exercise
Speed of recovery
Short–medium-term rehabilitation
Wound management
Long-term risk/benefit of surgery
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existing members with long-term musculoskeletal conditions,
three of whom had experience of advising a previous study
regarding research priorities and three of whom had experi-
ence of osteoporosis and/or fracture (either personal experi-
ence or as a relative/spouse or carer).
The resultant survey had four sections (representing the
four topics), each containing 10 stems. Responders were
asked to indicate their top three items (stems) within each
topic. A fifth question asked respondents to indicate their most
important topic out of the four sections. Finally, participants
were asked about their age, gender, self-reported diagnosis of
osteoporosis and fracture history. The full e-survey is avail-
able in Supplementary Data.
The e-survey was built within a freely available Web tool
(Survey Monkey) and a URL link to the e-survey was dissem-
inated to approximately 16,000 supporters of the UKNational
Osteoporosis Society (NOS) in one monthly e-newsletter, in
December 2015. The e-survey was also advertised via social
media, via a page on the society’s website and the society’s
quarterly membership magazine.
The e-survey remained open for 1 month. After this pe-
riod, responses were exported into Excel. Descriptive statis-
tics were used to describe demographics of responders and
the top three items within each topic. In order to identify the
top 10 priorities overall, a weighting was necessary.
Participants had to choose three items within each question,
therein simply showing the count of responses for each item
would not reflect what the participants felt was most impor-
tant across all four categories. The responses to all 40 stems
were pooled, with each individual’s three items in their most
important topic (as indicated by question 5) receiving a dou-
ble weighting.
A latent class analysis was applied to identify a substantive
number of clusters with different combinations of binary re-
sponses. Latent class analysis (LCA) is a statistical method for
finding subtypes of related cases (latent classes) from multivari-
ate categorical data. For example, it can be used to find distinct
diagnostic categories given presence/absence of several symp-
toms, types of attitude structures from survey responses, consum-
er segments from demographic and preference variables, or ex-
aminee subpopulations from their answers to test items. The
results of LCA can also be used to classify cases to their most
likely latent class. The data analysis for this paper was generated
using SAS software 9.3[Copyright © 2002–2010 by SAS
Institute Inc., Cary, NC, USA]. The optimum number of classes
was determined by a combination of the following: (1)
goodness-of-fit statistics (Akaike Information Criteria, Bayesian
Information Criteria (BIC), sample size-adjusted BIC, and the
Lo-Mendell-Rubin adjusted likelihood ratio test (LRT)); (2) un-
certainty of classification measures such as the entropy and av-
erage posterior probabilities; (3) class size of at least 10% of the
sample and (4) clinical relevance and interpretability. Labels for
each cluster were determined by consensus between four authors
(CJ, ZP, PJ, SG). Where the contingency table is larger than
2 × 2, Fisher-Freeman-Halton exact test of independence was
used to quantify the association between responses within any
cluster and age, fracture, diagnosis of osteoporosis, and gender.
Results
Characteristics of responders
One thousand one hundred eighty-eight respondents (approxi-
mately 7.4%) completed the e-survey. Of the responders,
87.4% were female, 295 (24.8%) aged under 60, 537 (45.2%)
aged 60–69 and 356 (30%) aged 70 or over. The majority
reported a diagnosis of osteoporosis (79%) and 39.6% reported
a history of fracture. Those not reporting a history of osteopo-
rosis or fracture were assumed to have an interest in the condi-
tion by virtue of their interest in the NOS; this group is likely to
represent individuals who consider themselves at risk of
Table 2 Characteristics of e-survey responders
Number (%)
Female
Male
Missing
1038 (87.4)
88 (7.4)
62 (5.2)
Age
under 50
50–59
60–69
70–79
80 and over
Not recorded
95 (8.0)
200 (16.8)
537 (45.2)
250 (21.0)
50 (4.2)
56 (4.7)
Self-reported diagnosis of osteoporosis
Yes
No
Unsure
Missing
939 (79.0)
176 (14.8)
12 (1.0)
61 (5.1)
Self-reported history of fracture
Yes
Fracture sitea
Radial
Hip
Vertebral
Pelvis
Humerus
Other
Number of fracture sites
1 fracture site
2 fracture sites
≥3 fracture sites
No
Unsure
Missing
471 (39.6)
149
37
227
14
48
176
322
103
45
547 (46.0)
122 (10.3)
48 (4.0)
a Participants could select multiple responses; hence, total does not equal
471
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osteoporosis in addition to family members, carers or possibly
health care professionals. Interestingly, 10.3% reported being
unsure as to their fracture history. The NOS were not able to
release information about the gender or age of their
membership/mailing list due to data protection reasons, and
therefore, it is not possible to draw any conclusions about the
difference between responders and non-responders.
Characteristics of responders are further detailed in Table 2.
Highest scoring items in weighted analysis: top ten
The most important topic was rated as ‘understanding and
preventing osteoporosis’ (n = 470, 39.6%); followed by
‘treating osteoporosis’ (n = 373, 31.4%); ‘living with osteo-
porosis’ (n = 255, 21.5%) and ‘treating fractures’ (n = 51,
4.3%). Thirty-nine respondents did not answer this question
and these were not included in the weighted analysis. The top
scoring three items within each topic are detailed in
Supplementary data Table S1. The top three items overall
were ‘Having easy access to advice and information from
health professionals’, ‘Understanding further the safety and
benefit of osteoporosis drug treatments’ and ‘Identifying the
condition early by screening’. The top ten items determined
by the weighted analysis are shown in Table 3.
Latent class analysis
Using LCAwithin each topic, distinct clusters of responses to
related items were identified, as described in Table 4.
Although we aimed for a class size of at least 10% of the
sample, clinical interpretation of the third topic, ‘treating os-
teoporosis’, revealed six to be the optimum number of clus-
ters, despite one cluster representing only 8.8% of the sample.
The summary of latent class diagnostics are detailed in
Supplementary Tables S2–S5.
Responses in questions 1 and 2 (understanding and
preventing osteoporosis, and living with osteoporosis) were
associated with self-reported history of fracture (p < 0.001,
p = 0.03) (Fig. 1), but not with age or gender. Responses in
questions 1 (understanding and preventing osteoporosis), but
not question 2 (living with osteoporosis) were associated with
self-reported history of diagnosis of osteoporosis (p < 0.001).
Responses in questions 3 and 4 (treating osteoporosis and
treating fractures) were associated with age (p = 0.048,
p = 0.03), but not with self-reported history of fracture, diag-
nosis of osteoporosis or gender.
Those with prior fracture had a higher probability than
those without prior fracture of rating itemswithin ‘understand-
ing causes’ (21.1 vs 15.7%, Fig. 1a) and ‘managing the effects
of the condition’ (41 vs 32.3%, Fig. 1b) as important. Those
with a self-reported diagnosis of osteoporosis had a lower
probability than those without diagnosis of rating items in
the cluster ‘promoting early diagnosis’ (33.9 vs 48.9%) as
important and a higher probability of rating items in the cluster
‘understanding causes’ (20.0 vs 10.2%) as important. Those
without prior fracture had a higher probability than those with
prior fracture of rating items in the cluster ‘self-management’
(21.0 vs 12.9%, Fig. 1a) and support and information (22.1 vs
14.9%, Fig. 1b) as important. Those aged 70 and over had a
higher probability than those aged under 70 of rating items in
the cluster ‘monitoring drug effectiveness’ (17.7 vs 12.9%,
Fig. 2a) and acute fracture care (42.3 vs 33.2%, Fig. 2b) as
important. Those aged under 70 had a higher probability than
those aged 70 and over of rating items within the clusters
‘self-management’ (19.8 vs 13.3%, Fig. 2a) and ‘medium to
long term impact of fracture’ as important (41.1% vs 30.0%,
Fig. 2b).
Table 3 Top 10 items overall
Weighted
scorea
Number (%) of
participants
who rated as
important
1. Having easy access to advice and information from health professionals 872 758 (63.8)
2. Identifying the condition early by screening 798 585 (49.2)
3. Understanding further the safety and benefit of osteoporosis drug treatment 797 593 (49.9)
4. The impact of osteoporosis on being able to do daily activities 674 543 (45.7)
5. The effect of osteoporosis and osteoporosis drugs on fracture healing 656 640 (53.9)
6. Improving confidence to reduce fear of fracture 627 539 (45.4)
7. Pain associated with the condition 619 497 (41.8)
8. Identifying which types of exercise are best after fracture 617 604 (50.8)
9. Understanding further the role of diet in keeping bones healthy 577 405 (34.1)
10. Managing osteoporosis when you have other ongoing health conditions 570 467 (39.3)
aDerived by pooling responses to all 40 stems, with each individual’s three items in their most important topic (as indicated by question 5) receiving a
double weighting. Range of weighted scores = 25–872; median = 442
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Discussion
This study reports for the first time, topics of importance to
public and patients in the research of osteoporosis and frac-
ture. Currently, the existing published research priorities for
osteoporosis are detailed only in national guidance docu-
ments. Published research recommendations largely focus on
safety, benefit and optimal duration of drug treatment, algo-
rithms for screening and fracture risk assessment and further
epidemiology to understand causes of osteoporosis [16–18];
the SIGN guidance in the UK included recommendations for
research relating to nutrition and optimal frequency of DXA
scanning and the National Osteoporosis Federation include
research questions relating to exercise treatments, assessing
bone strength, assessing and reducing falls and diagnosing
vertebral fractures [19, 20]. Some national guidance docu-
ments do not contain any specific research recommendations
[21, 22].
This work emphasises that patients and public members
would value further health services research into information
giving, primary care management and non-pharmacological
management in addition to studies on safety and benefit of
drugs, and studies that explore outcomes other than fracture.
Within the top three, screening and safety and benefit of drugs
are aligned with established research recommendations.
However, the number one area of importance, having easy
access to information from health professionals, is not repre-
sented in guideline research recommendations. This finding is
concordant with priority setting in other long-term conditions,
both musculoskeletal and others, where education and com-
munication are highly rated [2, 23, 24].
The top ten features non-drug aspects of management such
as exercise and diet; again, this is in line with findings from a
review of JLA priority setting partnerships in 14 long-term
conditions where only 18% of the top ten research uncer-
tainties relating to treatment and concerned drugs [9]. This is
important because there is a significant mismatch between the
volume of ongoing trials relating to drug treatment and patient
priorities [9]. Research into self-management has been rated
an important priority by patients in priority setting exercises in
joint pain and other long-term conditions such as asthma [25,
26]. The top ten list also highlights the important outcomes to
patients with evidence that pain, fear of fracture and difficulty
with activities of daily living need to be prioritised in future
research, in addition to fracture prevention.
By drawing together clusters of similar items which did not
score so highly individually, the latent class analysis findings
are useful to further illustrate areas of priority. Of the most
frequent clusters, primary care management stands out as a
topic of importance that is not represented in the top ten,
highlighting the importance of health services research in this
area. Specific survey items within the primary care cluster
included the evaluation of annual review clinics for patientsT
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with osteoporosis and improving care and support from pa-
tients’ general practitioners (family physicians). ‘Increasing
scientific knowledge’ is a further area of importance identified
in the latent class analysis, which is of interest given that there
is a perception that patients will not prioritise basic science
research uncertainties, although other work with patients has
demonstrated that patients do value biomedical research [27].
The Fischer’s exact testing demonstrated that individuals with
self-reported diagnoses of fracture and osteoporosis were
more likely to rate items related to ‘understanding causes’ as
important which is perhaps not a finding of surprise. Older
individuals were more likely than younger individuals to rate
research into drugs, and less likely to rate self-management as
important. This is in keeping with findings from a study of
0
100
200
300
400
500
600
Yes No Unsure
Fracture History
Promong early diagnosis Self-management
Increasing scienﬁc knowledge Understanding causes
0
100
200
300
400
500
600
UnsureNoYes
Fracture History
Support and informaon Managing the eﬀects of the condion
Managing fear of fracture Managing pain
A
B
Fig. 1 Number of patients in each cluster with and without fracture: questions 1 and 2
0
100
200
300
400
500
600
not say
Safety and beneﬁt of medicaon and supplements
Monitoring drug eﬀecveness
Self-management
Monitoring the condion
Personalised medicine
Primary care management
0
100
200
300
400
500
600
Less than 50 50-59 60-69 70-79 80 or older Would rather Less than 50 50-59 60-69 70-79 80 or older would
rather not
say
Opmising return to funcon
Medium to long term impact of fracture management
Acute fracture care (diagnosis and management)
A
B
Fig. 2 Number of patients in each cluster by age: questions 3 and 4
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patients with joint pain which found older patients were more
likely to consider medical interventions important [26].
Focusing on the views of patients and public alone, in
contrast to other popular priority setting methods where clini-
cians are also involved, ensures health professionals do not
influence patient and caregiver responses. However, our study
is subject to some limitations. Although the response rate was
less than 10%, the total number of respondents numbered over
a thousand, and was in keeping with [28], or in excess of, the
number of respondents to similar e-surveys in other national
priority setting exercises [29]. The survey was predominantly
available electronically and so may not have included the
views of those without access to the Internet. Paper surveys
were available, although none were requested. Government
statistics in the UK suggest that Internet use in the elderly is
on the increase with four in ten adults over 75 and 74% adults
aged 65–75 accessing the Internet [30]. However, in view of
the fact that the prevalence of osteoporotic fractures in general
(particularly hip and vertebral) increases with age, our age
distribution may not have been entirely representative. The
survey may not have represented some minority groups; we
did not collect ethnicity data. Similarly, although men are less
likely to have osteoporosis than women, proportionately they
may have been under-represented in our responders.
However, in the latent class analysis, those men who did re-
spond did not differ in their priorities to women.
Criticisms of the priority setting approaches in general in-
clude the lack of specificity of the resultant top ten items/
research questions [31]. Unlike clinicians and researchers, pa-
tients think in terms of broad themes and quality of life out-
comes rather than specific questions and interventions [32].
Translating research priority lists into commissioning briefs
for funders is essential to make these priorities meaningful.
Techniques for this include further work with patients and
public to scope out the details of the topics and developing
research recommendations using the EPICOT format (evi-
dence, population, intervention, comparator, outcome and
time period) [4]. Further work to ‘evidence map’ the existing
knowledge, to compare with priorities and identify gaps
would also be useful [33].
Conclusion
This study reports for the first time, the research priorities of
patients and public with respect to osteoporosis and fracture
identified through a national e-survey. The findings have
added to existing recommendation by identifying new topics,
particularly, highlighting that ‘easy access to information from
health professionals’ is of the highest importance to patients.
Our partnership with the NOS will ensure that these priorities
are positively realised and not resigned to history as another
top ten. The findings from this research will be incorporated
into the new research strategy for the charity, which will out-
line the journey the NOS research programme plans to embark
on in order to bring about real improvements to the lives of
people affected by osteoporosis.
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